benzothiazole has been researched along with Disease Models, Animal in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 7 (70.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akunuri, R; Bhargava, SK; Jadala, C; Kamal, A; Reddy, MS; Reddy, TS; Reddy, VG; Srihari, P; Sultana, F; Wlodkowic, D | 1 |
| Arac, D; Bozkurt, EC; Bozkurt, H; Egilmez, R; Kaya, I; Ozer, H; Ozpinar, H | 1 |
| Ahuja, P; Arya, SK; Malik, S; Siddiqui, N | 1 |
| Alam, MS; Ali, Y; Bano, S; Dhulap, A; Haider, S; Hamid, H; Javed, K; Kharbanda, C; Nazreen, S | 1 |
| Chang, Y; Jung, JC; Jung, KH; Kang, MK; Kim, HK; Kim, TJ; Kim, YH; Lee, GH; Lee, J; Ryeom, HK | 1 |
| Abraha, A; Hall, GF; Honson, NS; Jensen, JR; Kuret, J | 1 |
| Besidski, Y; Brown, W; Bylund, J; Dabrowski, M; Dautrey, S; Griffin, AM; Harter, M; Horoszok, L; Hu, Y; Johnson, D; Johnstone, S; Jones, P; Kers, I; Kolmodin, K; Labarre, M; Labrecque, D; Laird, J; Leclerc, S; Lundström, T; Martino, J; Maudet, M; Munro, A; Nylöf, M; Penwell, A; Rotticci, D; Slaitas, A; Sundgren-Andersson, A; Svensson, M; Terp, G; Villanueva, H; Walpole, C; Zemribo, R | 1 |
| Can, OD; Ozkay, UD; Ozkay, Y; Oztürk, Y | 1 |
| Debnath, ML; Holt, DP; Huang, GF; Klunk, WE; Mathis, CA; Shao, L; Wang, Y | 1 |
| Barker, AL; Bates, GP; Beunard, JL; Hockly, E; Holt, K; Lowden, PA; Moffitt, H; Moolman, DL; Revington, AP; Sathasivam, K; Sunshine, S; Tse, J; Wanker, EE; Woodman, B | 1 |
10 other study(ies) available for benzothiazole and Disease Models, Animal
| Article | Year |
|---|---|
Pyrazolo-benzothiazole hybrids: Synthesis, anticancer properties and evaluation of antiangiogenic activity using in vitro VEGFR-2 kinase and in vivo transgenic zebrafish model.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Apoptosis; Benzothiazoles; Cell Cycle; Cell Line, Tumor; Cell Movement; Cell Proliferation; Disease Models, Animal; DNA Damage; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; HEK293 Cells; Humans; Membrane Potential, Mitochondrial; Molecular Structure; Neovascularization, Pathologic; Pyrazoles; Structure-Activity Relationship; Vascular Endothelial Growth Factor Receptor-2; Wound Healing; Zebrafish | 2019 |
Comparison of the Effects of Contractubex Gel and Benzothiazole After Topical Application in an Experimental Model of Epidural Fibrosis in Rats.
Topics: Administration, Topical; Allantoin; Animals; Benzothiazoles; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Drug Combinations; Epidural Space; Fibrosis; Heparin; Kidney Diseases; Laminectomy; Male; Microscopy; Plant Extracts; Random Allocation; Rats, Wistar | 2018 |
Design of benzothiazole-1,3,4-thiadiazole conjugates: synthesis and anticonvulsant evaluation.
Topics: Animals; Anticonvulsants; Benzothiazoles; Brain; Disease Models, Animal; Drug Design; Electroshock; gamma-Aminobutyric Acid; Liver; Male; Mice; Molecular Structure; Pentylenetetrazole; Rats, Wistar; Seizures; Structure-Activity Relationship; Thiadiazoles | 2013 |
Synthesis and evaluation of pyrazolines bearing benzothiazole as anti-inflammatory agents.
Topics: Animals; Anti-Inflammatory Agents; Benzothiazoles; Binding Sites; Carrageenan; Catalytic Domain; Celecoxib; Cell Line; Cell Survival; Cyclooxygenase 2; Disease Models, Animal; Edema; Enzyme Activation; Mice; Molecular Docking Simulation; Pyrazoles; Rats; Rats, Wistar; Structure-Activity Relationship; Sulfonamides; Tumor Necrosis Factor-alpha | 2014 |
Gadolinium Nanoparticles Conjugated with Therapeutic Bifunctional Chelate as a Potential T1 Theranostic Magnetic Resonance Imaging Agent.
Topics: Animals; Benzothiazoles; Cell Line, Tumor; Cell Proliferation; Chelating Agents; Colloids; Conjunctiva; Disease Models, Animal; Dynamic Light Scattering; Fibroblasts; Gadolinium; Humans; Liver; Magnetic Resonance Imaging; Mice; Nanoparticles; Solutions; Spectroscopy, Fourier Transform Infrared; Static Electricity; Theranostic Nanomedicine; Tissue Distribution; Water | 2016 |
Small-molecule mediated neuroprotection in an in situ model of tauopathy.
Topics: Animals; Benzothiazoles; Central Nervous System; Disease Models, Animal; Dose-Response Relationship, Drug; Lampreys; Neurons; Neuroprotective Agents; Recombinant Fusion Proteins; tau Proteins; Tauopathies | 2009 |
Potent and orally efficacious benzothiazole amides as TRPV1 antagonists.
Topics: Amides; Animals; Benzothiazoles; Disease Models, Animal; Dose-Response Relationship, Drug; Humans; Inflammation; Molecular Structure; Pain; Rats; Recombinant Proteins; Solubility; Structure-Activity Relationship; TRPV Cation Channels | 2012 |
Effect of benzothiazole/piperazine derivatives on intracerebroventricular streptozotocin-induced cognitive deficits.
Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Avoidance Learning; Benzothiazoles; Cognition Disorders; Disease Models, Animal; Maze Learning; Memory; Motor Activity; Piperazines; Rats; Rats, Wistar; Streptozocin | 2012 |
Development of a PET/SPECT agent for amyloid imaging in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Animals; Benzothiazoles; Binding, Competitive; Brain; Carbon Radioisotopes; Cerebellum; Disease Models, Animal; Female; Frontal Lobe; Humans; Iodine Radioisotopes; Metabolic Clearance Rate; Mice; Mice, Transgenic; Molecular Structure; Plaque, Amyloid; Positron-Emission Tomography; Radioligand Assay; Thiazoles; Tomography, Emission-Computed, Single-Photon | 2004 |
Evaluation of the benzothiazole aggregation inhibitors riluzole and PGL-135 as therapeutics for Huntington's disease.
Topics: Animals; Benzothiazoles; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Genotype; Huntington Disease; Male; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Transgenic; Neuroprotective Agents; Organ Culture Techniques; Riluzole; Thiazoles | 2006 |